Linda Duska

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Robert E. Bristow, Linda Duska, Nicholas C Lambrou et al. · Cancer · 2000 · 323 citations

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny et al. · New England Journal of Medicine · 2023 · 316 citations · Full text

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

Ana Oaknin, Lucy Gilbert, Anna V. Tinker et al. · Journal for ImmunoTherapy of Cancer · 2022 · 300 citations · Full text

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 296 citations

Advanced Cervical Cancer, Cervical Cancer, Cervical Health +9

Endometrial Cancer in Women 40 Years Old or Younger

Linda Duska, Audrey P. Garrett, Bo R. Rueda et al. · Gynecologic Oncology · 2001 · 238 citations

Medicine, Endometriosis, Carcinoma +8